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ABSTRACT
The identification of quantitative trait loci (QTLs)
of small effect size that underlie complex traits
poses a particular challenge for geneticists due to
the large sample sizes and large numbers of genetic
markers required for genomewide association scans.
An efficient solution for screening purposes is to
combine single nucleotide polymorphism (SNP)
microarrays and DNA pooling (SNP-MaP), an
approach that has been shown to be valid, reliable
and accurate in deriving relative allele frequency
estimates from pooled DNA for groups such as
cases and controls for 10K SNP microarrays.
However, in order to conduct a genomewide associ-
ation study many more SNP markers are needed. To
this end, we assessed the validity and reliability of
the SNP-MaP method using Affymetrix GeneChip
Mapping 100K Array set. Interpretable results
emerged for 95% of the SNPs (nearly 110 000 SNPs).
We found that SNP-MaP allele frequency estimates
correlated 0.939 with allele frequencies for 97 605
SNPs that were genotyped individually in an inde-
pendent population; the correlation was 0.971 for
26 SNPs that were genotyped individually for the
1028 individuals used to construct the DNA pools.
We conclude that extending the SNP-MaP method
to the Affymetrix GeneChip Mapping 100K Array
set provides a useful screen of >100 000 SNP markers
for QTL association scans.
INTRODUCTION
With the advent of highly multiplexed microarray systems for
single nucleotide polymorphism (SNP) genotyping that can
genotype hundreds of thousands of SNPs (1) genomewide
association scans are underway, although problems remain
(2,3). A major problem for the investigation of common
disorders and complex traits is that large samples are needed
to detect reliably the many quantitative trait loci (QTLs) of
very small effect size likely to be responsible for the ubiquit-
ous heritability of these traits (4). Because microarrays are
expensive and can only be used once, employing SNP microar-
rays to genotype large samples is not economically viable for
most researchers.
One way to screen large samples is to pool DNA for
groups such as cases and controls (5). We have combined
the strengths of microarrays to genotype large numbers of
SNPs and DNA pooling to genotype large samples by geno-
typing pooled DNA on microarrays, a method we call SNP
microarrays and pools (SNP-MaP). SNP-MaP allele frequency
estimates for groups such as cases and controls (or low and
high individuals for quantitative traits) can be compared to
nominate SNPs that show the greatest allele frequency differ-
ences; these nominated SNPs can then be confirmed with
individual genotyping and traditional parametric statistics.
We have shown that pooled DNA can be genotyped reliably
on microarrays with 10 000 SNPs (6,7) and we have used
the SNP-MaP method and 10K SNP microarrays in a multi-
stage design to identify four SNPs associated with cognitive
disability and ability in a sample of 6000 children (8). Until
now, our research has applied the SNP-MaP method to the
Affymetrix GeneChip Mapping 10K Array which uses a
single endonuclease restriction digestion and a single primer
set to amplify >10 000 SNPs distributed throughout the
genome. Advances in microarray technology, coupled with
increased resolution of the human genome sequence and its
SNPs, have led to the recent development of the Affymetrix
GeneChip Mapping 100K Array-set (9). The 100K microar-
ray set genotypes 116 204 SNPs, with a median and mean
intermarker distance of 8.5 and 23.6 kb, respectively, with
92% of the genome within 100 kb of a SNP. Even though
genomewide association studies are likely to require >100 000
SNP genetic markers (10), the 100K microarray set represents
an important step towards conducting systematic genomewide
associations.
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As described in the following section, there are important
differences between the 10K and 100K microarrays which
warrant the present investigation which assesses whether
the SNP-MaP method can be extended from the 10K micro-
array to the 100K microarray set.
The 100K microarray-set assay
Although the assay procedure and microarray technology for
the 100K microarray set is similar to that of the 10K micro-
array, there are four important differences. First, the 10K
microarray used just one restriction endonuclease (XbaI)
and one microarray, whereas the 100K microarray set uses
a second restriction endonuclease (HindIII) and a second
microarray. The 100K XbaI microarray genotypes 58 960
SNPs and the HindIII microarray genotypes 57 244 SNPs.
The use of a second restriction endonuclease and so many
additional SNPs could affect SNP-MaP results.
Secondly, similar to the 10K microarray, enzyme digestion
is followed by preferential amplification of fragments of a
certain size. However, the 10K microarray uses Taq poly-
merase, which preferentially amplifies fragments in the
range of 250–1000 bp, whereas the 100K microarray set
uses Platinum pfx polymerase (Invitrogen Corporation),
which preferentially amplifies larger fragments of digested
DNA in the range of 250–2000 bp. This amplicon size rep-
resents 300 Mb of sequence in comparison with 60 Mb of
sequence generated in the 10K microarray. The larger amp-
licon size of the 100K microarray set could reduce the number
of copies generated during the extension phase of PCR and
thus make 100K SNP-MaP allele frequency estimates less
accurate than the 10K microarray, which could especially
affect estimates based on pooled DNA.
Thirdly, the feature size of the 100K microarray set has
been downsized from 18 to 8 mm2 to enable a higher density
of probes on each microarray. This might decrease the reli-
ability and accuracy of deriving allele frequency estimates
from pooled DNA, as fewer copies of oligonucleotide probes
are available for DNA hybridization.
Finally, the SNPs on the 10K microarray were preferentially
selected for assay performance from a starting set of 55 605
SNPs. For the 100K microarray set, SNPs were selected
from a starting set of 3 031 331 SNPs, with 1 833 423 SNPs
from dbSNP (11) and the SNP Consortium (12) in addition to
1 197 908 SNPs discovered by Perlegen Sciences (13). Of
these, 535 564 SNPs were predicted to be in XbaI or HindIII
genomic DNA sites, and following in silico and empirical
screening, a final set of 116 204 SNPs was selected. The larger
numbers of SNPs raises the possibility that some are less
well characterized and may be less reliable.
Study design
These differences between the 10K and 100K microarray
assays warrant an investigation of the reliability, validity and
accuracy of the SNP-MaP method as applied to the Affymetrix
GeneChip mapping 100K microarray set. Using five
independent DNA pools consisting of >200 individuals
each, reliability was assessed by comparing the SNP-MaP
allele frequency estimates for the five pools. In addition, we
compared allele frequency estimates for the 7956 SNPs
common to both the 10K microarray and the 100K microarray
set. Validity was assessed by comparing SNP-MaP allele
frequency estimates with allele frequencies obtained by
individual genotyping in two ways. First, we compared our
SNP-MaP estimates with individually genotyped results for
SNPs on the 100K microarray set from a publicly available
reference sample of 42 Caucasian individuals. Second, we
individually genotyped DNA from subjects in the five DNA
pools for 26 SNPs on the 100K microarray set.
We also used a 100K microarray set to genotype an indi-
vidual reference genomic DNA sample provided by Affymet-
rix as a positive internal control to ensure all steps of the assay
were performed correctly.
MATERIALS AND METHODS
Samples
Five independent pools of DNA were created from a
sample of 1028 white Caucasian individuals (538 females
and 490 males) randomly selected from a community-based
sample of >14 000 children in the Twins Early Develop-
ment Study [TEDS; see (14)], which we used in an
SNP-MaP study of cognitive ability and disability with the
10K microarray (8).
DNA quantification and pool construction
DNA samples were extracted from buccal swabs (15), quan-
tified using a spectrophotometer (260 nm) and diluted to
a target concentration of 50 ng/ml. Each sample was sub-
sequently quantified in triplicate using fluorimetry (employing
PicoGreen dsDNA quantification reagent; Cambridge Bios-
cience, UK) and samples that were accurately quantified
(±0.5 ng/ml) were accepted for pooling. Each individual’s
DNA was randomly assigned to one of five DNA pools,
thus providing five independent pools constructed from
between 204 and 206 individuals. Each individual contributed
79.1 ng of DNA to a DNA pool. Each pool concentration
ranged from 13.33 to 13.57 ng/ml.
SNP microarray allelotyping of pooled DNA
Because pooled DNA can be used only to estimate allelic
frequency, not genotypic frequency, we refer to allelotyping
rather than genotyping. Each of the five DNA pools was allelo-
typed using the GeneChip Mapping 100K Array set in
accordance with the standard protocol for individual DNA
samples (see the GeneChip Mapping 100K Assay Manual
for full protocol). Each microarray was scanned using the
GeneChip scanner 3000 and GeneChip Operating software
(GCOS) v1.1.1 with patch 5. Cell intensity (.cel) files were
generated and subsequently saved and transported as Cabinet
(.CAB) files (using Data Transfer Tool v1.1) to a workstation
that contained GCOS software v1.2. Using GCOS v1.2,
new .cel files were generated and analyzed using GeneChip
DNA Analysis Software (GDAS) v3.0.
Each of the five DNA pools and a reference DNA individual
provided by the manufacturer (sample number 100103) was
assayed on a separate microarray set. Each sample was
independently amplified before hybridization.
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Generation of SNP-MaP allele frequency estimates
The 10K microarray used a Modified Partitioning Around
Medoids (MPAM) mapping algorithm to analyze the cell
intensity data of the labeled DNA that had hybridized to
the oligonucleotide probes (16). The MPAM mapping algo-
rithm used relative allele signals (RAS), a measure of the
intensities of the perfect match (PM) probes for alleles A
and B of an SNP, to make genotype calls. However, the
SNP-MaP method bypasses genotype calls, using instead
the average of RAS 1 (sense strand) and RAS 2 (anti-sense
strand) values (RASAV) as a quantitative index of allele
frequencies in pooled DNA (7).
For the 100K microarray set, a new model-based genotyp-
ing algorithm has been developed by Affymetrix, called the
dynamic modeling (DM) mapping algorithm (17), which no
longer generates RAS scores. Instead, we generated RAS
scores manually using the RAS score algorithm (see
Affymetrix GeneChip DNA Analysis Software users’
guide for full information on the algorithm used to derive
RAS values) with the raw probe intensity data exported as
a .txt file. Because the calculation of RAS values is compu-
tationally intensive, we wrote a script in R that calculates RAS
1 and RAS 2 values for each SNP. These programs are freely
available to download at http://sgdp.iop.kcl.ac.uk/oleo/affy.
Correction for differential florescence signals
In addition, we investigated the effect of correcting signal
intensities for differential florescence—a process known as
k-correction (18). In theory, a heterozygous individual
should yield a 50:50 ratio of florescence intensities for
each of the two alleles. In practice, however, this is often
not the case; the presence of a single base pair change in a
25mer oligo will subtly alter the hybridization kinetics and
produce unique florescence intensity. This can have important
consequences when comparing allele-frequency estimates
from DNA pools with those derived from individual
genotyping.
k-correction requires heterozygous scores for all SNPs on
the array set, and consequently would require the genotyping
of hundreds of individuals, especially for rare SNPs. For this
reason, we have established a central resource for the accu-
mulation of RAS 1 and RAS 2 values from Affymetrix arrays
for heterozygous individuals: http://cogent.iop.kcl.ac.uk/
rcorrection.cogx (19). Using this resource, k can be estimated
from independent heterozygotes, currently ranging from 1 to
89 individuals for the 100K microarray set, and from 1 to 40
individuals for the 10K microarray set.
The heterozygous scores for SNPs on the 100K microarray
set were downloaded, and k-values were derived for each SNP
using the following equation.
k ¼ Correction Value
1  Correction Value
where Correction Value is the average of the RAS 1 and RAS
2 values for the panel of individual heterozygotes. For indi-
vidual samples, RAS 1 and RAS 2 values vary between 0 (BB
homozygote) and 1 (AA homozygote). The RAS 1 and RAS 2
values for AB heterozygotes cluster (on average) around 0.5,
and so k is 1.0 if there is no differential florescence.
k-corrected SNP-MaP allele frequency estimates for allele
A (Aˆ) of a SNP can be calculated as follows:
Aˆ ¼ A
Aþ kð1  AÞ
where A is the RASAV score for allele A of a SNP.
Investigation of non-specific hybridization
The 10K MPAM mapping algorithm, in addition to calculating
RAS 1 and RAS 2 scores, assessed the degree of non-
specific hybridization of the sample DNA to the probes on
the microarray by comparing the intensities for the mismatch
probes (MM) with the intensities of the Perfect Match (CAM)
probes to calculate a discrimination score, called DSsnp. This
calculation is no longer performed with the DM mapping
algorithm for the 100K microarray set, and so we calculated
the DSsnp for each SNP, again using the freely available script
in R (http://sgdp.iop.kcl.ac.uk/oleo/affy; see Affymetrix
GeneChip DNA Analysis Software users’ guide for full
information on the algorithm used to derive DSsnp).
DSsnp values should range from 0 to 1 with higher scores
indicating greater discrimination between PM and MM probes
and less non-specific hybridization. However, as the 25mer
probes only differ by 1 bp between PM and MM probes, it
is not uncommon for MM intensities to fluoresce at similar
and sometimes even higher intensities. In cases where MM
intensities are higher than PM intensities, the DSsnp value will
be negative. Non-specific hybridization of sample DNA to
the probes on the microarray produces background noise
that might especially affect allele frequency estimates for
pooled DNA. For this reason, DSsnp values were calculated
for each SNP on the microarray set and compared between the
DNA pools and individual sample.
For our analysis, although DSsnp values were obtained for
each SNP on the microarray we focus only on SNPs with a
DSsnp value >0.04.
Individual genotyping
We compared SNP-MaP allelic frequency estimates from
pooled DNA allelotyped on the 100K microarray set to estim-
ates based on individual genotyping in two ways. First, we
compared our SNP-MaP estimates to individually genotyped
results for a reference sample of 42 Caucasian individuals
that is publicly available from the NetAffx Analysis
Centre (http://www.affymetrix.com/analysis/index.affx), a
web-based tool providing extensive annotation for each
SNP on the 100K microarray set (20). The 42 individuals
were obtained from the human variation panel (http://
coriell.umdnj.edu/) and genotyped by Affymetrix, and are
of mixed gender, self declared Caucasian, unrelated and
healthy.
Second, for 26 SNPs from the microarray set, we individu-
ally genotyped DNA from the 1028 subjects who were
included in the five DNA pools. Individual genotyping was
performed by Kbiosciences, which uses a mixture of compet-
itive allele specific PCR (KASPar) and TaqMan genotyping
assays (http://www.kbioscience.co.uk/). We assessed the
genotyping error rate for each SNP using blind duplicate
samples and members of MZ twin pairs.
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RESULTS
Detection rates for pooled DNA
Good hybridization signal intensities were obtained for all
five DNA pools. SNPs were excluded from analysis if there
was inadequate discrimination between specific versus non-
specific hybridization of DNA to the probes using a DSsnp
value <0.04. As shown in Table 1, SNP-MaP allele frequency
estimates were obtained for 109 994 SNPs (94.7%) across all
five DNA pools for the 100K microarray-set: 54 778 SNPs
(92.9%) on the XbaI microarray and 55 216 SNPs (96.5%) on
the HindIII microarray. Table 1 also lists the number of SNPs
estimates successfully obtained on fewer than five DNA pools.
Detection rate and reproducibility for a reference
individual
DNA from a reference individual provided by Affymetrix was
assayed at the same time as the DNA pools in order to ensure
that the assay was performed correctly. GDAS was used to
derive genotype calls for the individual sample, with DSsnp
value again set at <0.04. Good hybridization signal intensities
were obtained, and genotype calls were obtained for 110 738
SNPs (95.3%) of which 55 186 were on the XbaI microarray
and 55 552 SNPs were on the HindIII microarray. Comparing
our genotypes for the reference individual to the published
genotypes, the agreement was 99.4% for XbaI and 99.8% for
HindIII. This confirms that the assay was performed correctly,
and that no sample contamination occurred.
Reliability of SNP-MaP allele frequency estimates
Reliability: comparing SNP-MaP estimates across five
independent DNA pools for the 100K microarray set. In
order to assess reliability, the SNP-MaP allele frequency
estimates for each of the five DNA pools were compared. It
should be reiterated that each of the five DNA pools is con-
structed from different individuals and assayed on a separate
microarray set. Thus, differences between SNP-MaP allele
frequency estimates incorporate sampling variance (i.e. true
allele frequency differences between the pools), pool construc-
tion error, as well as all other sources of measurement error.
Our analysis focused on the subset of SNPs on the microar-
ray set for which k-values were available and where 100K
SNP-MaP allele frequency estimates were obtained across
all five DNA pools (N ¼ 97 605 SNPs, of which 50 254
SNPs are on the XbaI microarray and 47 351 SNPs on the
HindIII microarray).
As shown in Table 2, the uncorrected SNP-MaP allele
frequency estimates were highly correlated across the five
DNA pools, ranging from 0.960 to 0.977 (average of 0.969)
across the XbaI and HindIII microarrays. As indicated by the
high correlations, the SNP-Map allele frequency differences
across DNA pools are small, ranging from 0.046 to 0.058
(average of 0.054). As expected for relative comparisons
between DNA pools (which is the goal for case–control stud-
ies), applying k-correction to the same set of SNPs had little
effect: the correlations across DNA pools ranged from 0.958
to 0.975 (average of 0.966) across both microarrays, and
the allele frequency differences across DNA pools ranged
from 0.047 to 0.06 (average of 0.056). The correlation between
the uncorrected and k-corrected allele frequency estimates
averaged across the five DNA pools was 0.980.
Presenting these differences as standard deviations (SDs) is
illuminating in relation to issues of power for the SNP-MaP
method. SDs for SNP-MaP allele frequency estimates across
the five DNA pools for both the XbaI and HindIII microarrays
are both similar and small (0.044 and 0.041, respectively).
Figure 1 illustrates the distribution of SDs across the 100K
microarray set for 109 994 SNPs for which data were available
for all five DNA pools.
Using the average SD of 0.043, we modeled power in
STATA with the ‘sampsi’ command. Five independent
case pools and five independent control pools would yield
80% power (P ¼ 0.05, two-tailed) to detect SNP-MaP
allele frequency differences of 0.075 between groups (e.g.
0.500 versus 0.575) and 99% power to detect differences
of 0.115.
Reliability: comparing SNP-MaP estimates for the 10K
and 100K microarray sets. As an additional check on the
reliability of the Affymetrix GeneChip Mapping 100K set,
the same five DNA pools were also assayed on the previously
validated Affymetrix GeneChip Mapping 10K Array
Xba I 131 array. SNPs (7956) were assayed both on the
10K XbaI microarray and the 100K XbaI microarrays; for
6597 of these SNPs, SNP-MaP allele frequency estimates
were available for both the 10K and 100K microarrays
for all five DNA pools. Again, because we wished to examine
the effect of k-correction, the analysis focuses on 5708 SNPs
for which both 10K k-values and 100K k-values were
Table 1. Number of SNPs successfully estimated from the 100K microarray
set across five or fewer of the independent DNA pools
Number of
DNA pools
XbaI HindIII Combined
Frequency % Frequency % Frequency %
5 54 778 92.9 55 216 96.5 109 994 94.5
4 2350 4.0 1481 2.6 3831 3.3
3 978 1.6 337 0.6 1315 1.1
2 515 1.4 130 0.2 645 0.6
1 241 0.4 60 0.1 301 0.3
0 98 0.2 20 0.0 118 0.1
58 960 100 57 244 116 204 100
Table 2. Correlations for uncorrected and k-corrected SNP-MaP allele
frequency estimates between five independent DNA pools
Pool 1 Pool 2 Pool 3 Pool 4
Uncorrected
Pool 1
Pool 2 0.970 (0.053)
Pool 3 0.973 (0.050) 0.977 (0.046)
Pool 4 0.966 (0.056) 0.970 (0.053) 0.973 (0.050)
Pool 5 0.960 (0.055) 0.966 (0.055) 0.970 (0.052) 0.962 (0.058)
k-Corrected
Pool 1
Pool 2 0.967 (0.055)
Pool 3 0.970 (0.052) 0.975 (0.047)
Pool 4 0.962 (0.058) 0.967 (0.055) 0.970 (0.051)
Pool 5 0.963 (0.057) 0.962 (0.057) 0.966 (0.054) 0.958 (0.060)
Values in parentheses are the mean allele frequency differences.
(N ¼ 97 605 SNPs).
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available. The uncorrected SNP-MaP allele frequency
estimates for the 5708 SNPs were compared across the 10K
SNP-MaP and 100K SNP-MaP assays. Similar to the results
for the 100K comparisons across five DNA pools, the correla-
tions between the 10K and 100K allelic frequency estimates
were high, ranging from 0.911 to 0.967 with an average cor-
relation of 0.940. The mean differences are also small, ranging
from 0.055 to 0.090 (average of 0.073). Again, applying
k-correction to the same set of SNPs had little effect; the
correlations ranged from 0.909 to 0.959 (average of 0.934),
and the mean differences ranged from 0.054 to 0.081 (average
of 0.069).
Validity: comparison of SNP-MaP allele frequencies to
individual genotyping
Validity comparisons with the NetAffx dataset. Focusing on
the subset of SNPs that yielded an allele frequency estimate
across all five DNA pools and also had k-values (N ¼ 96 605
SNPs), the SNP-MaP allele frequency estimates for the five
DNA pools were correlated with population allele frequency
estimates from NetAffx.
As shown in Table 3, the uncorrected SNP-MaP allele fre-
quency estimates (RASAV scores) correlate strongly with
NetAffx allele frequency estimates, ranging from 0.933 to
0.943 across the five DNA pools with an average of 0.939,
indicating that RASAV values for the 100K microarray set
provide a valid measure of allele frequency in pooled
DNA. The average difference in allele frequency estimates
was 0.081. The scatterplot shown in Figure 2a indicates
that despite the high correlation and the low average allele
frequency differences, some of the allele frequency differ-
ences are substantial.
k-correction of SNP-MaP allele frequency estimates
increased the average correlation between SNP-MaP esti-
mates of allele frequencies and NetAffx allele frequency
estimates from 0.939 to 0.959. The mean difference between
k-corrected microarray estimates and NetAffx was atten-
uated from 0.081 to 0.066. The scatterplot shown in
Figure 2b (as compared with Figure 2a) illustrates the higher
correlation and smaller differences for k-corrected scores.
Validity comparisons with individual genotyping for the same
individuals. We would expect that correspondence between
allele frequency estimates from pooled DNA and from indi-
vidual genotyping would be greater when both sets of estim-
ates are based on the same individuals. For 26 SNPs on
the 100K microarray set, individuals in the five DNA pools
were individually genotyped in order to obtain allele fre-
quency estimates based on the same sample, rather than the
independent NetAffx population (20).
As shown in Table 4, the uncorrected SNP-MaP allele
frequency estimates (RASAV scores) correlate well with abso-
lute allele frequency estimates as determined by individual
genotyping, with an average correlation of 0.903 and a
mean difference of 0.065 (ranging from 0.007 to 0.155). As
expected, k-correction of the pooled allele frequency esti-
mates increased the correlation to 0.971, and decreased the
mean allele frequency difference to 0.036 (ranging from 0.008
to 0.077).
However, it should be noted that using just two independent
DNA pool comparisons might result in an unacceptable level
of false positive results in a case–control association study. For
example, looking at the 26 SNPs in Table 4 we observe SNP-
MaP allele frequency differences between independent pools
(e.g. pool 1 versus pool 2) ranging from 6 to 27%. Of these,
68.08% are true positive results (i.e. the difference between the
two DNA pools at the individual genotyping level is >5%).
Therefore, in order to minimize false positive results in a case–
control association study using this approach we recommend
the use of multiple DNA pools of independent samples (and
parametric test statistics) and an independent replication stage.
Importantly, we observed a very small number of false neg-
ative results (3.84%).
Table 3. Correlations for uncorrected and k-corrected SNP-MaP and
NetAffx allele frequency estimates for five independent DNA pools
Array Combined XbaI HindIII
N SNPs 97 605 50 254 47 351
Uncorrected SNP-MaP estimates
Pool 1 0.940 (0.081) 0.929 (0.086) 0.950 (0.076)
Pool 2 0.940 (0.081) 0.931 (0.084) 0.949 (0.077)
Pool 3 0.943 (0.079) 0.936 (0.081) 0.949 (0.077)
Pool 4 0.933 (0.085) 0.925 (0.087) 0.941 (0.082)
Pool 5 0.939 (0.080) 0.936 (0.081) 0.942 (0.079)
Average 0.939 (0.081) 0.931 (0.084) 0.946 (0.078)
k-Corrected SNP-MaP estimates
Pool 1 0.960 (0.065) 0.953 (0.068) 0.967 (0.062)
Pool 2 0.960 (0.066) 0.957 (0.066) 0.964 (0.066)
Pool 3 0.964 (0.063) 0.960 (0.064) 0.967 (0.062)
Pool 4 0.953 (0.070) 0.948 (0.072) 0.958 (0.069)
Pool 5 0.957 (0.066) 0.962 (0.063) 0.953 (0.070)
Average 0.959 (0.066) 0.956 (0.067) 0.962 (0.066)
Values in parentheses are the mean allele frequency differences.
Figure 1. Histogram of SDs for 109 994 SNPs.
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Non-specific hybridization
Non-specific hybridization for SNPs on the 100K microarray
set. For SNPs with DSsnp values >0.04, the distribution
of DSsnp values for the XbaI and HindIII microarrays
were compared for each of the five DNA pools. Average
DSsnp values were similar for XbaI and HindIII: 0.408 and
0.418, respectively. The distribution of DSsnp values obtained
for the reference individual is also similar (average DSsnp
value of 0.37, for XbaI and 0.38 for HindIII). These results
(a) (b)
Figure 2. Scatter plot of (a) uncorrected and (b) k-corrected SNP-MaP allele frequency estimates from pooled DNA versus NetAffxTM allele frequency estimates
from individual genotyping. The scatterplot shown is for DNA pool 1 for 97 605 SNPs.
Table 4. Summary of SNP-MaP allele frequency estimates versus individual genotyping estimates for 26 SNPs
DbSNP ID Uncorrected SNP-MaP allele frequency estimates k-Value Individual genotyping (IG) allele
frequency
estimates
Average difference
between SNP-MaP and IG
Pool 1 Pool 2 Pool 3 Pool 4 Pool 5 Pool 1 Pool 2 Pool 3 Pool 4 Pool 5 Uncorrected k-Corrected
rs1002666 0.34 (0.31) 0.20 (0.18) 0.21 (0.18) 0.24 (0.22) 0.47 (0.44) 1.16 0.23 0.22 0.23 0.27 0.27 0.08 0.08
rs10493112 0.57 (0.53) 0.59 (0.55) 0.57 (0.53) 0.57 (0.53) 0.59 (0.55) 1.19 0.55 0.53 0.55 0.55 0.53 0.04 0.02
rs1343726 0.31 (0.32) 0.29 (0.29) 0.30 (0.31) 0.30 (0.31) 0.37 (0.38) 0.97 0.31 0.33 0.28 0.29 0.32 0.03 0.03
rs1386468 0.31 (0.32) 0.32 (0.32) 0.31 (0.31) 0.27 (0.27) 0.23 (0.23) 0.97 0.32 0.34 0.29 0.32 0.28 0.03 0.03
rs1480952 0.33 (0.3) 0.35 (0.32) 0.36 (0.32) 0.29 (0.26) 0.31 (0.28) 1.17 0.29 0.29 0.28 0.28 0.27 0.05 0.02
rs2050632 0.60 (0.58) 0.60 (0.58) 0.65 (0.62) 0.65 (0.63) 0.67 (0.65) 1.10 0.57 0.60 0.64 0.58 0.60 0.03 0.03
rs2254209 0.23 (0.23) 0.18 (0.18) 0.18 (0.18) 0.21 (0.21) 0.2 (0.2) 0.97 0.22 0.18 0.19 0.21 0.20 0.01 0.01
rs2292734 0.48 (0.41) 0.58 (0.51) 0.55 (0.48) 0.53 (0.46) 0.46 (0.39) 1.31 0.37 0.41 0.46 0.40 0.37 0.12 0.05
rs2382591 0.18 (0.16) 0.16 (0.14) 0.18 (0.16) 0.20 (0.18) 0.18 (0.17) 1.11 0.17 0.15 0.14 0.13 0.16 0.03 0.02
rs2409411 0.73 (0.7) 0.77 (0.74) 0.78 (0.75) 0.72 (0.69) 0.62 (0.59) 1.17 0.67 0.66 0.68 0.67 0.61 0.07 0.04
rs2593963 0.41 (0.39) 0.48 (0.46) 0.50 (0.48) 0.54 (0.52) 0.54 (0.52) 1.09 0.42 0.39 0.42 0.42 0.43 0.08 0.07
rs2832886 0.57 (0.6) 0.47 (0.5) 0.48 (0.51) 0.54 (0.58) 0.53 (0.56) 0.87 0.60 0.59 0.54 0.53 0.56 0.05 0.03
rs2834036 0.69 (0.66) 0.67 (0.65) 0.62 (0.59) 0.67 (0.64) 0.67 (0.65) 1.12 0.66 0.66 0.61 0.63 0.59 0.03 0.02
rs3811021 0.72 (0.85) 0.70 (0.84) 0.65 (0.81) 0.61 (0.78) 0.58 (0.75) 0.45 0.81 0.81 0.80 0.79 0.81 0.15 0.03
rs3935801 0.34 (0.36) 0.30 (0.31) 0.29 (0.3) 0.37 (0.39) 0.45 (0.47) 0.92 0.40 0.36 0.34 0.33 0.41 0.05 0.05
rs4128492 0.74 (0.8) 0.58 (0.67) 0.64 (0.72) 0.65 (0.73) 0.59 (0.68) 0.69 0.77 0.77 0.75 0.76 0.76 0.12 0.06
rs4509467 0.55 (0.56) 0.72 (0.73) 0.72 (0.73) 0.64 (0.66) 0.65 (0.66) 0.95 0.67 0.64 0.69 0.69 0.63 0.06 0.06
rs4754752 0.79 (0.78) 0.80 (0.79) 0.83 (0.82) 0.81 (0.8) 0.82 (0.81) 1.05 0.80 0.79 0.79 0.77 0.79 0.03 0.02
rs6691482 0.45 (0.4) 0.49 (0.44) 0.52 (0.47) 0.51 (0.46) 0.51 (0.46) 1.21 0.41 0.41 0.43 0.46 0.45 0.06 0.02
rs6763768 0.42 (0.34) 0.60 (0.52) 0.45 (0.36) 0.55 (0.46) 0.48 (0.39) 1.43 0.34 0.41 0.34 0.39 0.37 0.13 0.05
rs7197569 0.57 (0.54) 0.65 (0.63) 0.55 (0.53) 0.58 (0.55) 0.58 (0.56) 1.09 0.53 0.61 0.56 0.57 0.57 0.02 0.02
rs725272 0.64 (0.58) 0.62 (0.55) 0.67 (0.61) 0.68 (0.62) 0.70 (0.64) 1.30 0.58 0.58 0.57 0.62 0.60 0.07 0.02
rs726523 0.31 (0.29) 0.23 (0.21) 0.28 (0.26) 0.28 (0.26) 0.32 (0.29) 1.13 0.27 0.19 0.24 0.26 0.22 0.05 0.03
rs758240 0.64 (0.74) 0.57 (0.67) 0.40 (0.51) 0.43 (0.54) 0.63 (0.73) 0.64 0.67 0.64 0.60 0.61 0.65 0.10 0.07
rs9301694 0.20 (0.34) 0.21 (0.36) 0.08 (0.16) 0.19 (0.32) 0.16 (0.28) 0.48 0.32 0.34 0.31 0.33 0.31 0.16 0.05
rs991684 0.26 (0.35) 0.25 (0.33) 0.25 (0.34) 0.28 (0.37) 0.20 (0.28) 0.67 0.31 0.30 0.29 0.32 0.27 0.05 0.04
Average 0.065 0.036
Values in parentheses show k-corrected SNP-MaP allele frequency estimates.
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indicate that DNA pools are not inherently noisier than
individual samples.
DISCUSSION
Despite reasons to expect that SNP-MaP estimates for the
100K microarray set might not be as reliable and valid as
the 10K microarray, the present results for the 100K microar-
ray set are as promising as our previous results for the 10K
microarray (7). For the 100K microarray set, allelotyping
of SNPs for pooled DNA was as successful as individual
genotyping—95% of SNPs yielded interpretable results
(DSsnp 5 0.04), which means that results for nearly
110 000 SNPs can be expected for the 100K microarray
set. Concerning reliability, the average correlation
among the ﬁve subpools in the present study using the
100K microarray set was 0.969; our previous work on
the 10K yielded an average correlation of 0.955. Concern-
ing validity, the average correlation for the 100K microar-
ray set was 0.939 between our SNP-MaP allele frequency
estimates using pooled DNA allelotyped and individual
genotyping results from the NetAffx standardization sam-
ple; for the 10K microarray, the average correlation was
0.904.
As expected, k-correction made no difference for reliability
which involves relative comparisons between comparing
allele frequency estimates for different groups; it should be
emphasized that relative comparisons between groups such as
case versus control groups is the purpose of SNP-MaP. For
validity comparisons between SNP-MaP allele frequency
estimates from pooled DNA and estimates based on individual
genotyping, k-correction improved the correlations.
Despite the high reliability of SNP-MaP estimates, the aver-
age difference in allele frequency estimates from pooled
DNA is 0.036. In other words, SNP-MaP can only detect allele
frequency differences >0.036 between two DNA pools. In
order to increase the sensitivity to detect allele frequency
differences between groups, multiple DNA pools of independ-
ent subsamples from each group are recommended. The use of
multiple independent DNA pools also permits the use of para-
metric statistics because it assesses sampling variation. With
five independent subpools as in the present experiment, the
SD is 0.041, which implies that allele frequency differences of
0.075 between groups (e.g. allele frequencies of 0.500 for
cases and 0.575 for controls) can be detected with 80%
power (P ¼ 0.05, two-tailed). Doubling the number of replic-
ate DNA pools from 5 to 10 pools does not alter the SD but
will alter the SEM by a function of the square root of the
number of replicates. That is, with five replicates we observed
a mean SEM of 0.19, whilst 10 replicates should yield an SEM
of0.013, which would yield 80% power to detect differences
of 0.053 and 99% power to detect differences of 0.082.
Although doubling the cost of an experiment seems a consid-
erable price to pay for these small gains in power, we advocate
the use of 10 replicates in order to maximize power to detect
QTLs of small effect size.
We also recommend that individual genotyping be used to
confirm SNP-MaP screening. Because SNP-MaP estimates of
allele frequency involve errors of estimation due to pooling
DNA, group differences in allele frequency estimates will be
reduced when SNPs nominated by SNP-MaP are individually
genotyped. For this reason, it is unlikely that allele frequency
differences between groups as small as 0.05 can be detected
reliably—a more reasonable target is SNP-MaP differences
>0.10. Power to detect allele frequency differences at the
confirmation stage of individual genotyping depends directly
on sample size.
Although power is the crucial issue in detecting QTL asso-
ciations of small effect size, the issue of the balance between
false positive and false negative results becomes especially
important when so many tests are conducted. For example,
using a nominal P-value of 0.05, 5000 statistically significant
results are expected by chance alone; winnowing the true
results from the false positives will be difficult to resolve
statistically. Although the obvious statistical solution is to
increase the P-value to protect against false positive results
due to multiple testing (21), a multistage approach could pro-
vide a better balance between false positive and false negative
findings (3). In the end, the solution to this conundrum will
be empirical rather than statistical: independent replication.
It is generally agreed that >100 000 SNPs are needed for
genomewide association scans. Because the SNP-MaP
approach works equally well for the 100K microarray set as
for the 10K microarray, we anticipate that the approach will
also work for the 500K microarray set which is now available.
It should be mentioned that the SNP-MaP approach is also
likely to work for any other SNP microarrays such as
gene-based microarrays, or microarrays with functional
SNPs that would permit more powerful direct association ana-
lyses rather than indirect association analyses that rely on
linkage disequilibrium between SNPs and QTLs.
Limitations of the SNP-MaP approach include the addi-
tional error that comes from estimating an average allele
frequency from pooled DNA rather than from each individual.
Accuracy would of course be better if each individual’s
DNA were genotyped on separate microarrays, but the
expense would prohibit most researchers from studying the
very large samples needed to detect QTLs of very small
effect size. For example, assuming a cost of £500 per 100K
microarray set, it would cost £500 000 to genotype a sample
of 1000 individuals on separate microarrays. In comparison,
a SNP-MaP case–control study using 10 independent case
pools and 10 independent control pools with a replication
design of an additional 10 case and 10 control pools would
cost £30 000, including the cost of DNA pool construction.
The cost of confirmation with individual genotyping will
then depend largely upon how many statistically significant
SNPs are selected. Assuming a cost of £0.05 per genotype,
even if 4700 SNPs (far more SNPs than would reasonably
be followed up) were individually genotyped the total SNP-
MaP study cost would be half that of using separate
microarrays—£250 000.
Our results indicate that SNP-MaP approach yields substan-
tial reliability and validity to screen for the largest allele fre-
quency differences between case and control groups. A greater
limitation is that pooled DNA can only be used to estimate
allele frequencies rather than genotypic frequencies, which
means that haplotypes cannot be investigated at the SNP-
MaP screening stage, although haplotypes could be incorpor-
ated into individual genotyping strategies at the confirmation
stage. These costs are offset by the tremendous benefits of
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screening many thousands of SNPs using the very large sam-
ples needed to detect QTLs of small effect size.
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